{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T05:38:31Z","timestamp":1772948311691,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To identify and quantify the level of CD34+CD133+CD309+ circulating angiogenic cells (CAC) and explore factors associated with the level of CAC in patients with SLE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The peripheral blood mononuclear cells of consecutive SLE patients and demographically matched healthy controls (HC) were extracted and identified, enumerated and compared for CAC levels by multi-colour flow cytometry based on the EULAR Scleroderma Trials and Research (EUSTAR) recommendation. Meta-analyses were performed by combining the current and previous case\u2013control studies, aiming to increase the statistical power to discern the difference in CAC level between SLE patients and HC. Mixed-model meta-regression was conducted to explore potential demographic and clinical factors that were associated with CAC level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A lower level of CAC was found in 29 SLE patients compared with 24 HC [mean (s.d.) 10.76 (13.9) vs 24.58 (25.4) cells\/ml, P\u2009=\u20090.015]. Random-effects meta-analyses of the current and six previously published case\u2013control studies involving 401 SLE patients and 228 HC revealed a lower CAC level compared with HC (standardized mean difference\u2009=\u2009\u20132.439, P\u2009=\u20090.001). Meta-regression analysis demonstrated that HCQ use was associated with a more discrepant CAC level between both groups (P\u2009=\u20090.01115).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>SLE patients had a significantly lower CD34+CD133+CD309+ CAC level than HC, and HCQ use was associated with a more discrepant CAC level between SLE patients and HC. This study triggers further observational, interventional and mechanistic studies to address the beneficial impact of HCQ on the functionality of CAC in SLE patients.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa875","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T03:55:56Z","timestamp":1607486156000},"page":"3936-3944","source":"Crossref","is-referenced-by-count":8,"title":["CD34+CD133+CD309+ circulating angiogenic cell level is reduced but positively related to hydroxychloroquine use in SLE patients\u2014a case\u2013control study and meta-regression analysis"],"prefix":"10.1093","volume":"60","author":[{"given":"Jinghui","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"},{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nien Yee","family":"Kow","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"},{"name":"Division of Rheumatology, University Medicine Cluster, National University Health System, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Yin","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology (ICMB), Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Marie","family":"Fairhurst","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology (ICMB), Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-7829","authenticated-orcid":false,"given":"Anselm","family":"Mak","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"},{"name":"Division of Rheumatology, University Medicine Cluster, National University Health System, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"2021080220113016200_keaa875-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/419029","article-title":"The pathology of T cells in systemic lupus erythematosus","volume":"2014","author":"Mak","year":"2014","journal-title":"J Immunol Res"},{"key":"2021080220113016200_keaa875-B2","doi-asserted-by":"crossref","first-page":"e000270","DOI":"10.1136\/lupus-2018-000270","article-title":"Interferon pathway in SLE: one key to unlocking the mystery of the disease","volume":"6","author":"R\u00f6nnblom","year":"2019","journal-title":"Lupus Sci Med"},{"key":"2021080220113016200_keaa875-B3","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1291\/hypres.31.2105","article-title":"Flow-mediated vasodilation as a diagnostic modality for vascular failure","volume":"31","author":"Inoue","year":"2008","journal-title":"Hypertens Res"},{"key":"2021080220113016200_keaa875-B4","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1038\/s41598-017-07574-1","article-title":"Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression","volume":"7","author":"Mak","year":"2017","journal-title":"Sci Rep"},{"key":"2021080220113016200_keaa875-B5","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s10753-014-9940-z","article-title":"Decreased flow-mediated dilatation in patients with systemic lupus erythematosus: a meta-analysis","volume":"37","author":"Wang","year":"2014","journal-title":"Inflammation"},{"key":"2021080220113016200_keaa875-B6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jaut.2006.09.008","article-title":"Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients","volume":"27","author":"Kiss","year":"2006","journal-title":"J Autoimmun"},{"key":"2021080220113016200_keaa875-B7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0961203306074842","article-title":"Impaired endothelial function in systemic lupus erythematosus","volume":"16","author":"Piper","year":"2007","journal-title":"Lupus"},{"key":"2021080220113016200_keaa875-B8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4252\/wjsc.v6.i3.355","article-title":"Endothelial progenitor cells in cardiovascular diseases","volume":"6","author":"Lee","year":"2014","journal-title":"World J Stem Cells"},{"key":"2021080220113016200_keaa875-B9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1291\/hypres.30.133","article-title":"Circulating endothelial progenitor cells, C-reactive protein and severity of coronary stenosis in Chinese patients with coronary artery disease","volume":"30","author":"Wang","year":"2007","journal-title":"Hypertens Res"},{"key":"2021080220113016200_keaa875-B10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/01.STR.0000149944.15406.16","article-title":"Endothelial progenitor cells during cerebrovascular disease","volume":"36","author":"Ghani","year":"2005","journal-title":"Stroke"},{"key":"2021080220113016200_keaa875-B11","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/HJH.0b013e32828e506d","article-title":"Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients","volume":"25","author":"Pirro","year":"2007","journal-title":"J Hypertens"},{"key":"2021080220113016200_keaa875-B12","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s00125-012-2590-5","article-title":"Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers","volume":"55","author":"Van Ark","year":"2012","journal-title":"Diabetologia"},{"key":"2021080220113016200_keaa875-B13","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar2283","article-title":"Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus","volume":"9","author":"Moonen","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"2021080220113016200_keaa875-B14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00296-010-1730-9","article-title":"Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification","volume":"32","author":"Baker","year":"2012","journal-title":"Rheumatol Int"},{"key":"2021080220113016200_keaa875-B15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/ard.2006.065631","article-title":"Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus","volume":"66","author":"Westerweel","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021080220113016200_keaa875-B16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/ard.2008.091918","article-title":"EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells","volume":"68","author":"Distler","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021080220113016200_keaa875-B17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2011-200713","article-title":"Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols","volume":"71","author":"Kuwana","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021080220113016200_keaa875-B18","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/sctm.16-0360","article-title":"Endothelial progenitors: a consensus statement on nomenclature","volume":"6","author":"Medina","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"2021080220113016200_keaa875-B19","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.exphem.2007.04.002","article-title":"Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors","volume":"35","author":"Case","year":"2007","journal-title":"Exp Hematol"},{"key":"2021080220113016200_keaa875-B20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12015-019-09881-8","article-title":"Human endothelial colony forming cells express intracellular CD133 that modulates their vasculogenic properties","volume":"15","author":"Rossi","year":"2019","journal-title":"Stem Cell Rev Rep"},{"key":"2021080220113016200_keaa875-B21","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1161\/ATVBAHA.107.144972","article-title":"Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors","volume":"27","author":"Timmermans","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021080220113016200_keaa875-B22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.yjmcc.2005.07.003","article-title":"Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells","volume":"39","author":"Urbich","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"2021080220113016200_keaa875-B23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2021080220113016200_keaa875-B24","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021080220113016200_keaa875-B25","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2021080220113016200_keaa875-B26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2021080220113016200_keaa875-B27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/bmj.39057.406644.68","article-title":"What is heterogeneity and is it important?","volume":"334","author":"Fletcher","year":"2007","journal-title":"BMJ"},{"key":"2021080220113016200_keaa875-B28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"2021080220113016200_keaa875-B29","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"key":"2021080220113016200_keaa875-B30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar3700","article-title":"Endothelial progenitor cells: a new player in lupus?","volume":"14","author":"Haque","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2021080220113016200_keaa875-B31","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1634\/stemcells.2006-0783","article-title":"Hemogenic endothelial progenitor cells isolated from human umbilical cord blood","volume":"25","author":"Wu","year":"2007","journal-title":"Stem Cells"},{"key":"2021080220113016200_keaa875-B32","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"2021080220113016200_keaa875-B33","first-page":"1448","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group","volume":"87","author":"Moher","year":"2000","journal-title":"Br J Surg"},{"key":"2021080220113016200_keaa875-B34","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses","author":"Wells","journal-title":"Ottawa Hospital Research Institute, 2015"},{"key":"2021080220113016200_keaa875-B35","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.4049\/jimmunol.0902199","article-title":"A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs","volume":"184","author":"Denny","year":"2010","journal-title":"J Immunol"},{"key":"2021080220113016200_keaa875-B36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/cts.12137","article-title":"Influence of elevated levels of C-reactive protein on circulating endothelial progenitor cell function","volume":"7","author":"Fasing","year":"2014","journal-title":"Clin Transl Sci"},{"key":"2021080220113016200_keaa875-B37","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2007.02.052","article-title":"C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus","volume":"49","author":"Ridker","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2021080220113016200_keaa875-B38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.0000151875.21836.AE","article-title":"Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis","volume":"111","author":"Grisar","year":"2005","journal-title":"Circulation"},{"key":"2021080220113016200_keaa875-B39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2005.035378","article-title":"Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells","volume":"65","author":"Herbrig","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2021080220113016200_keaa875-B40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mvr.2015.01.004","article-title":"Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis","volume":"98","author":"Andrigueti","year":"2015","journal-title":"Microvasc Res"},{"key":"2021080220113016200_keaa875-B41","first-page":"S19","article-title":"Low circulating level of CD133+KDR+cells in patients with systemic sclerosis","volume":"28","author":"Mok","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2021080220113016200_keaa875-B42","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/rheumatology\/kes152","article-title":"Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients","volume":"51","author":"Rodriguez-Carrio","year":"2012","journal-title":"Rheumatology (Oxford"},{"key":"2021080220113016200_keaa875-B43","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/07853890701329283","article-title":"Endothelial colony forming units: are they a reliable marker of endothelial progenitor cell numbers?","volume":"39","author":"Shantsila","year":"2007","journal-title":"Ann Med"},{"key":"2021080220113016200_keaa875-B44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/ten.2006.12.331","article-title":"Comparative analysis of methods for assessment of circulating endothelial progenitor cells","volume":"12","author":"George","year":"2006","journal-title":"Tissue Eng"},{"key":"2021080220113016200_keaa875-B45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40001-018-0352-7","article-title":"Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis","volume":"23","author":"Patschan","year":"2018","journal-title":"Eur J Med Res"},{"key":"2021080220113016200_keaa875-B46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13075-019-2015-7","article-title":"B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus","volume":"21","author":"Spinelli","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2021080220113016200_keaa875-B47","doi-asserted-by":"crossref","first-page":"e000286","DOI":"10.1136\/lupus-2018-000286","article-title":"Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE","volume":"5","author":"Casey","year":"2018","journal-title":"Lupus Sci Med"},{"key":"2021080220113016200_keaa875-B48","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood"},{"key":"2021080220113016200_keaa875-B49","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1002\/art.23035","article-title":"Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus","volume":"56","author":"Lee","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021080220113016200_keaa875-B50","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/art.37997","article-title":"Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress","volume":"65","author":"Kim","year":"2013","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa875\/35200731\/keaa875.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/8\/3936\/39543827\/keaa875.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/8\/3936\/39543827\/keaa875.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T20:34:41Z","timestamp":1697315681000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/8\/3936\/6053832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,1,25]]},"published-print":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa875","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,1,25]]}}}